Formulation & Delivery 2023
Oxford Global’s 9th Annual Formulation & Respiratory Drug Delivery Congress, 25 – 26 May 2023, London, UK will be attended by over 350 visionary leaders to network about the latest innovations in the field. With a revamped agenda, visionary leaders will be looking at novel approaches to both small & large molecule formulation development, exploring new drug delivery systems and stability & characterisation updates.
The event will be taking a deep dive into the following main themes:
- Day 1 Track 1: Small Molecule Drug Formulation
- Day 1 Track 2: Biologics Drug Delivery
- Day 1 Track 3: Bioanalysis: Stability, Characterisation, Developability
- Day 2 Track 1: Small Molecule Drug Delivery
- Day 2 Track 2: Multi Specific Antibodies, Cell Engagers & Other New Modalities
Key Speakers Include:
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
- Werngard Czechtizky, Executive Director, Head of Medicinal Chemistry, AstraZeneca
- Ben Van Hove, Scientific Director, Janssen
- Norbert Lauber, Director, Autoinjectors & Pump Systems, Novartis
- Pawel Stasiak, Pharma Development Director, Zentiva
- Yogeshwar Bachhav, Associate Director, AiCuris Anti-infective Cures AG Germany
- Kathy Wang, Associate Director, AstraZeneca
Featuring a series of dedicated interactive sessions:
- Panel Discussion: Developability Assessment
- Panel Discussion: Small Molecule Formulation – Future Developments, Complexity & Novel Technologies
- Workshop: Oral Delivery Of Biologics
- Roundtable: Sustainability In Formulation Development
- Roundtable: Implementing Novel Bioanalytical Technique
- Roundtable: Advancing Biologics & New Modalities Drug Formulation
Co-located with the Inhalation & Respiratory Drug Delivery Congress. More information contact [email protected].